Trial Profile
Phase I/II study of treosulfan + dacarbazine in chemonaive malignant melanoma patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Treosulfan (Primary) ; Dacarbazine
- Indications Malignant melanoma
- Focus Adverse reactions
- 05 Nov 2010 New trial record.